We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

82 hedge funds and large institutions have $24.7M invested in Lumos Pharma, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more capital invested

Capital invested by funds: $19.5M → $24.7M (+$5.2M)

6% less funds holding

Funds holding: 87 → 82 (-5)

13% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 23

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

67% less call options, than puts

Call options by funds: $28K | Put options by funds: $84K

Holders
82
Holders Change
-5
Holders Change %
-5.75%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
20
Reduced
23
Closed
16
Calls
$28K
Puts
$84K
Net Calls
-$56K
Net Calls Change
-$57K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.09M
2
WVP
Worth Venture Partners
New Jersey
+$407K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$373K
4
Invesco
Invesco
Georgia
+$199K
5
Bank of America
Bank of America
North Carolina
+$185K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$1.13M
2
AFM
Anson Funds Management
Texas
-$429K
3
OAM
Oxford Asset Management
United Kingdom
-$204K
4
Morgan Stanley
Morgan Stanley
New York
-$175K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$99.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
LA
26
LexAurum Advisors
Kansas
$101K – – –
Charles Schwab
27
Charles Schwab
California
$94K – – –
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$86K -$19.5K -1,310 -21%
AllianceBernstein
29
AllianceBernstein
Tennessee
$82K -$15.9K -1,067 -18%
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$79K +$731 +49 +1%
State of Wisconsin Investment Board
31
State of Wisconsin Investment Board
Wisconsin
$74K +$14.6K +978 +30%
Deutsche Bank
32
Deutsche Bank
Germany
$68K -$4.34K -291 -7%
VF
33
Virtu Financial
New York
$60K +$51.8K +3,474 New
Citadel Advisors
34
Citadel Advisors
Florida
$58K +$26.1K +1,751 +111%
IA
35
IFP Advisors
Florida
$53K +$45.1K +3,027 New
Canada Pension Plan Investment Board
36
Canada Pension Plan Investment Board
Ontario, Canada
$51K +$44.1K +2,957 New
FTIOP
37
Fiduciary Trust International of Pennsylvania
Pennsylvania
$48K +$41.4K +2,778 New
BIM
38
Bogle Investment Management
Massachusetts
$44K -$48.5K -3,253 -56%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$42K – – –
ARTA
40
A.R.T. Advisors
New York
$42K +$7.72K +518 +28%
State Board of Administration of Florida Retirement System
41
State Board of Administration of Florida Retirement System
Florida
$41K – – –
Millennium Management
42
Millennium Management
New York
$40K +$15.8K +1,057 +86%
AIG
43
American International Group
New York
$36K -$999 -67 -3%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$35K – – –
AG
45
Advisor Group
Arizona
$34K – – –
CS
46
Credit Suisse
Switzerland
$29K +$3.35K +225 +15%
FAM
47
Fenimore Asset Management
New York
$24K – – –
VOYA Investment Management
48
VOYA Investment Management
Georgia
$24K – – –
SBH
49
Segall Bryant & Hamill
Illinois
$21K – – –
AL
50
Arnhold LLC
New York
$19K – – –
1
2
3 4

LUMO Hedge Fund Activity: Q1 2019 in Review

82 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2019, worth a combined $24.7M — up 27% from $19.5M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of LUMO and 12 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 20 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.09M. The largest seller was JP Morgan Chase, cutting an estimated $1.13M.

  • 82 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2019, down from 87 in Q4 2018.
  • Funds reported $24.7M of Lumos Pharma, Inc. Common Stock stock for Q1 2019, up 27% quarter-over-quarter.
  • 12 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2019 and 16 closed out, a net change of -4 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2019 was Renaissance Technologies, an estimated $1.09M added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q1 2019 was JP Morgan Chase, an estimated $1.13M sold.

Based on aggregated 13F filings for Q1 2019.